Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized Double-Blind, Vehicle-Controlled, Parallel Group Study to Demonstrate the Efficacy and Safety of CD07805/47 Gel Applied Topically Once Daily in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea

NCT01355458 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT01355458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01355458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized Double-Blind, Vehicle-Controlled, Parallel Group Study to Demonstrate the Efficacy and Safety of CD07805/47 Gel Applied Topically Once Daily in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea
Lead sponsor
Galderma R&D
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2011
Completion date
December 31, 2011
Enrollment
260 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea